A citation-based method for searching scientific literature

Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
Times Cited: 130







List of co-cited articles
809 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.
Kerstin Rhiem, Hans-Joachim Bücker-Nott, Martin Hellmich, Holger Fischer, Beyhan Ataseven, Christine Dittmer-Grabowski, Kunibert Latos, Volker Pelzer, Manuela Seifert, Andrea Schmidt,[...]. Breast J 2019
11
9

Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
Irene Lopez-Perolio, Raphaël Leman, Raquel Behar, Vanessa Lattimore, John F Pearson, Laurent Castéra, Alexandra Martins, Dominique Vaur, Nicolas Goardon, Grégoire Davy,[...]. J Med Genet 2019
9
11

Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas.
Sock Hoai Chan, Weng Khong Lim, Nur Diana Binte Ishak, Shao-Tzu Li, Wei Lin Goh, Gek San Tan, Kiat Hon Lim, Melissa Teo, Cedric Ng Chuan Young, Simeen Malik,[...]. Sci Rep 2017
29
3

Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system.
Angeliki Delimitsou, Florentia Fostira, Despoina Kalfakakou, Paraskevi Apostolou, Irene Konstantopoulou, Christos Kroupis, Athanasios G Papavassiliou, Zdenek Kleibl, Efstratios Stratikos, Gerassimos E Voutsinas,[...]. Hum Mutat 2019
11
9

A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function.
Lea M Starita, Muhtadi M Islam, Tapahsama Banerjee, Aleksandra I Adamovich, Justin Gullingsrud, Stanley Fields, Jay Shendure, Jeffrey D Parvin. Am J Hum Genet 2018
56
1

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart,[...]. Cancer Discov 2012
249
1

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Keith Nykamp, Michael Anderson, Martin Powers, John Garcia, Blanca Herrera, Yuan-Yuan Ho, Yuya Kobayashi, Nila Patil, Janita Thusberg, Marjorie Westbrook,[...]. Genet Med 2017
246
1

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
Melissa S Cline, Rachel G Liao, Michael T Parsons, Benedict Paten, Faisal Alquaddoomi, Antonis Antoniou, Samantha Baxter, Larry Brody, Robert Cook-Deegan, Amy Coffin,[...]. PLoS Genet 2018
70
1

Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings.
Hannah Maynard, Zsofia K Stadler, Michael F Berger, David B Solit, Michele Ly, Maeve A Lowery, Diana Mandelker, Liying Zhang, Emmett Jordan, Imane El Dika,[...]. Cancer 2020
7
14

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
D Mandelker, M Donoghue, S Talukdar, C Bandlamudi, P Srinivasan, M Vivek, S Jezdic, H Hanson, K Snape, A Kulkarni,[...]. Ann Oncol 2019
39
2

Functional Categorization of BRCA1 Variants of Uncertain Clinical Significance in Homologous Recombination Repair Complementation Assays.
Peter Bouwman, Ingrid van der Heijden, Hanneke van der Gulden, Roebi de Bruijn, Merel E Braspenning, Setareh Moghadasi, Lodewyk F A Wessels, Maaike P G Vreeswijk, Jos Jonkers. Clin Cancer Res 2020
4
25

10-year performance of four models of breast cancer risk: a validation study.
Mary Beth Terry, Yuyan Liao, Alice S Whittemore, Nicole Leoce, Richard Buchsbaum, Nur Zeinomar, Gillian S Dite, Wendy K Chung, Julia A Knight, Melissa C Southey,[...]. Lancet Oncol 2019
60
1

Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.
Sean V Tavtigian, Marc S Greenblatt, Steven M Harrison, Robert L Nussbaum, Snehit A Prabhu, Kenneth M Boucher, Leslie G Biesecker. Genet Med 2018
118
1

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.
Clémence Basse, Claire Morel, Marie Alt, Marie Paule Sablin, Coralie Franck, Gaëlle Pierron, Céline Callens, Samia Melaabi, Julien Masliah-Planchon, Guillaume Bataillon,[...]. ESMO Open 2018
19
5

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
James X Sun, Yuting He, Eric Sanford, Meagan Montesion, Garrett M Frampton, Stéphane Vignot, Jean-Charles Soria, Jeffrey S Ross, Vincent A Miller, Phil J Stephens,[...]. PLoS Comput Biol 2018
94
1

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Sebastian M Waszak, Paul A Northcott, Ivo Buchhalter, Giles W Robinson, Christian Sutter, Susanne Groebner, Kerstin B Grund, Laurence Brugières, David T W Jones, Kristian W Pajtler,[...]. Lancet Oncol 2018
143
1

Variant Interpretation: Functional Assays to the Rescue.
Lea M Starita, Nadav Ahituv, Maitreya J Dunham, Jacob O Kitzman, Frederick P Roth, Georg Seelig, Jay Shendure, Douglas M Fowler. Am J Hum Genet 2017
124
1

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study.
Stefan Klek, Brandie Heald, Alex Milinovich, Ying Ni, Jame Abraham, Haider Mahdi, Bassam Estfan, Alok A Khorana, Brian J Bolwell, Petros Grivas,[...]. JNCI Cancer Spectr 2020
3
33

Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group.
Sean V Tavtigian, Marc S Greenblatt, David E Goldgar, Paolo Boffetta. Hum Mutat 2008
57
1

Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants.
Michael N Edmonson, Aman N Patel, Dale J Hedges, Zhaoming Wang, Evadnie Rampersaud, Chimene A Kesserwan, Xin Zhou, Yanling Liu, Scott Newman, Michael C Rusch,[...]. Genome Res 2019
9
11

A general framework for estimating the relative pathogenicity of human genetic variants.
Martin Kircher, Daniela M Witten, Preti Jain, Brian J O'Roak, Gregory M Cooper, Jay Shendure. Nat Genet 2014
1

Response to DNA damage of CHEK2 missense mutations in familial breast cancer.
Wendy Roeb, Jake Higgins, Mary-Claire King. Hum Mol Genet 2012
46
2

VarSome: the human genomic variant search engine.
Christos Kopanos, Vasilis Tsiolkas, Alexandros Kouris, Charles E Chapple, Monica Albarca Aguilera, Richard Meyer, Andreas Massouras. Bioinformatics 2019
439
1

Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer.
Rhode Bijlsma, Roel Wouters, Hester Wessels, Stefan Sleijfer, Laurens Beerepoot, Daan Ten Bokkel Huinink, Hester Cruijsen, Joan Heijns, Martijn P Lolkema, Neeltje Steeghs,[...]. ESMO Open 2020
6
16

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
1

Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.
Rick A C M Boonen, Amélie Rodrigue, Chantal Stoepker, Wouter W Wiegant, Bas Vroling, Milan Sharma, Magdalena B Rother, Nandi Celosse, Maaike P G Vreeswijk, Fergus Couch,[...]. Nat Commun 2019
19
5

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.
V Abkevich, K M Timms, B T Hennessy, J Potter, M S Carey, L A Meyer, K Smith-McCune, R Broaddus, K H Lu, J Chen,[...]. Br J Cancer 2012
328
1

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
91
1

Hereditary prostate cancer: epidemiologic and clinical features.
B S Carter, G S Bova, T H Beaty, G D Steinberg, B Childs, W B Isaacs, P C Walsh. J Urol 1993
407
1

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li,[...]. JAMA 2017
198
1

Accurate classification of BRCA1 variants with saturation genome editing.
Gregory M Findlay, Riza M Daza, Beth Martin, Melissa D Zhang, Anh P Leith, Molly Gasperini, Joseph D Janizek, Xingfan Huang, Lea M Starita, Jay Shendure. Nature 2018
242
1

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection.
Carolina Velázquez, Enrique Lastra, Francisco Avila Cobos, Luis Abella, Virginia de la Cruz, Blanca Ascensión Hernando, Lara Hernández, Noemí Martínez, Mar Infante, Mercedes Durán. J Transl Med 2020
3
33

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.
Tatiana Popova, Elodie Manié, Guillaume Rieunier, Virginie Caux-Moncoutier, Carole Tirapo, Thierry Dubois, Olivier Delattre, Brigitte Sigal-Zafrani, Marc Bollet, Michel Longy,[...]. Cancer Res 2012
299
1

Toward automation of germline variant curation in clinical cancer genetics.
Vignesh Ravichandran, Zarina Shameer, Yelena Kemel, Michael Walsh, Karen Cadoo, Steven Lipkin, Diana Mandelker, Liying Zhang, Zsofia Stadler, Mark Robson,[...]. Genet Med 2019
11
9

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Jingmei Li, Wei Xiong Wen, Martin Eklund, Anders Kvist, Mikael Eriksson, Helene Nordahl Christensen, Astrid Torstensson, Svetlana Bajalica-Lagercrantz, Alison M Dunning, Brennan Decker,[...]. Int J Cancer 2019
16
6

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
145
1

A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor.
Amélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, Yan Coulombe, Gemma Montalban, Simone da Costa E Silva Carvalho, Larissa Milano, Mandy Ducy, Giuliana De-Gregoriis, Graham Dellaire,[...]. Nucleic Acids Res 2019
18
5

Functional assays for analysis of variants of uncertain significance in BRCA2.
Lucia Guidugli, Aura Carreira, Sandrine M Caputo, Asa Ehlen, Alvaro Galli, Alvaro N A Monteiro, Susan L Neuhausen, Thomas V O Hansen, Fergus J Couch, Maaike P G Vreeswijk. Hum Mutat 2014
70
1


Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research.
Teri A Manolio, Douglas M Fowler, Lea M Starita, Melissa A Haendel, Daniel G MacArthur, Leslie G Biesecker, Elizabeth Worthey, Rex L Chisholm, Eric D Green, Howard J Jacob,[...]. Cell 2017
67
1

MutationTaster2: mutation prediction for the deep-sequencing age.
Jana Marie Schwarz, David N Cooper, Markus Schuelke, Dominik Seelow. Nat Methods 2014
1

ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variants.
Ronak Y Patel, Neethu Shah, Andrew R Jackson, Rajarshi Ghosh, Piotr Pawliczek, Sameer Paithankar, Aaron Baker, Kevin Riehle, Hailin Chen, Sofia Milosavljevic,[...]. Genome Med 2017
41
2

Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples.
Rebecca F Halperin, Winnie S Liang, Sidharth Kulkarni, Erica E Tassone, Jonathan Adkins, Daniel Enriquez, Nhan L Tran, Nicole C Hank, James Newell, Chinnappa Kodira,[...]. Front Oncol 2019
9
11

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.
Izabela Karbassi, Glenn A Maston, Angela Love, Christina DiVincenzo, Corey D Braastad, Christopher D Elzinga, Alison R Bright, Domenic Previte, Ke Zhang, Charles M Rowland,[...]. Hum Mutat 2016
36
2

First-line PARP inhibition in ovarian cancer - standard of care for all?
Susana N Banerjee, Christopher J Lord. Nat Rev Clin Oncol 2020
14
7

BRCAness revisited.
Christopher J Lord, Alan Ashworth. Nat Rev Cancer 2016
585
1

Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework.
Bryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, Deborah I Ritter, Maegan E Roberts, Ryan J Schmidt, Bryony A Thompson, Sharisse Jimenez, Mackenzie Trapp, Kristy Lee,[...]. Genet Med 2019
10
10

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
267
1

Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
Barbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, Petra Fiesel, Ruth Witt, Angelika Freitag, Miream Boudalil, Christopher Previti, Stephan Wolf, Sabine Schmidt,[...]. Eur J Cancer 2016
154
1

High-throughput functional evaluation of BRCA2 variants of unknown significance.
Masachika Ikegami, Shinji Kohsaka, Toshihide Ueno, Yukihide Momozawa, Satoshi Inoue, Kenji Tamura, Akihiko Shimomura, Noriko Hosoya, Hiroshi Kobayashi, Sakae Tanaka,[...]. Nat Commun 2020
13
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.